Forschung & Innovation
Publikationen
Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.
PMU Autor*in
Felix Eckstein
Alle Autor*innen
L Stefan Lohmander, Scarlett Hellot, Don Dreher, Eduard F W Krantz, Dawie S Kruger, Ali Guermazi, Felix Eckstein
Fachzeitschrift
ARTHRITIS AND RHEUMATISM
Kurzfassung
Keywords
MRI, QUANTITATIVE ASSESSMENT, INITIATIVE PROGRESSION SUBCOHORT, REGIONAL-ANALYSIS, PLACEBO-CONTROLLED TRIAL, CLINICALLY IMPORTANT DIFFERENCES, FEMOROTIBIAL CARTILAGE LOSS, DOUBLE-BLIND, GLUCOSAMINE SULFATE, PREDICTIVE-VALIDITY